VRTX - J&J Roche AstraZeneca poised to have highest orphan drug sales by end of decade
2024-04-28 13:00:22 ET
Orphan drugs -- medicines to treat rare diseases -- from Johnson & Johnson ( NYSE: JNJ ), Roche ( OTCQX:RHHBY ), and AstraZeneca ( NASDAQ: AZN ) will allow these companies to reign as the top 3 orphan drugmakers, by sales, in 2028....
J&J, Roche, AstraZeneca poised to have highest orphan drug sales by end of decade